robert s. warren
robert s. warren
Verified email at
Cited by
Cited by
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
RS Warren, H Yuan, MR Matli, NA Gillett, N Ferrara
The Journal of clinical investigation 95 (4), 1789-1797, 1995
Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis
K Kinkel, Y Lu, M Both, RS Warren, RF Thoeni
Radiology 224 (3), 748-756, 2002
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy
ST Pullarkat, J Stoehlmacher, V Ghaderi, YP Xiong, SA Ingles, A Sherrod, ...
The pharmacogenomics journal 1 (1), 65-70, 2001
Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains: association with endothelial cell …
D Guo, Q Jia, HY Song, RS Warren, DB Donner
Journal of Biological Chemistry 270 (12), 6729-6733, 1995
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B …
MM Bertagnolli, D Niedzwiecki, CC Compton, HP Hahn, M Hall, B Damas, ...
Journal of clinical Oncology 27 (11), 1814, 2009
Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction
TE Godfrey, SH Kim, M Chavira, DW Ruff, RS Warren, JW Gray, ...
The Journal of molecular diagnostics 2 (2), 84-91, 2000
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
NE Kemeny, D Niedzwiecki, DR Hollis, HJ Lenz, RS Warren, ...
Journal of Clinical Oncology 24 (9), 1395-1403, 2006
Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma
RS Warren, H Yuan, MR Matli, N Ferrara, DB Donner
Journal of Biological Chemistry 271 (46), 29483-29488, 1996
Tumor necrosis factor and the acute metabolic response to tissue injury in man.
HF Starnes, RS Warren, M Jeevanandam, JL Gabrilove, W Larchian, ...
The Journal of clinical investigation 82 (4), 1321-1325, 1988
Mutations of the PATCHED Gene in Several Types of Sporadic Extracutaneous Tumors
J Xie, RL Johnson, X Zhang, JW Bare, FM Waldman, PH Cogen, ...
Cancer research 57 (12), 2369-2372, 1997
β-Catenin regulates vascular endothelial growth factor expression in colon cancer
V Easwaran, SH Lee, L Inge, L Guo, C Goldbeck, E Garrett, M Wiesmann, ...
Cancer research 63 (12), 3145-3153, 2003
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial
S Mulvihill, R Warren, A Venook, A Adler, B Randlev, C Heise, D Kirn
Gene therapy 8 (4), 308-315, 2001
Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation
LW Wu, LD Mayo, JD Dunbar, KM Kessler, MR Baerwald, EA Jaffe, ...
Journal of Biological Chemistry 275 (7), 5096-5103, 2000
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
ME Lippman, JC Allegra, EB Thompson, R Simon, A Barlock, L Green, ...
New England Journal of Medicine 298 (22), 1223-1228, 1978
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis
F Coll, J Phelan, GA Hill-Cawthorne, MB Nair, K Mallard, S Ali, ...
Nature genetics 50 (2), 307-316, 2018
The acute metabolic effects of tumor necrosis factor administration in humans
RS Warren, HF Starnes, JL Gabrilove, HF Oettgen, MF Brennan
Archives of Surgery 122 (12), 1396-1400, 1987
Pancreatic adenocarcinoma
MA Tempero, JP Arnoletti, S Behrman, E Ben-Josef, AB Benson, JD Berlin, ...
Journal of the National Comprehensive Cancer Network 8 (9), 972-1017, 2010
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer.
PB Chapman, TJ Lester, ES Casper, JL Gabrilove, GY Wong, SJ Kempin, ...
Journal of Clinical Oncology 5 (12), 1942-1951, 1987
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy
FA Sinicrope, MR Mahoney, TC Smyrk, SN Thibodeau, RS Warren, ...
Journal of clinical oncology 31 (29), 3664, 2013
Intravascular adenoviral agents in cancer patients: lessons from clinical trials
T Reid, R Warren, D Kirn
Cancer gene therapy 9 (12), 979-986, 2002
The system can't perform the operation now. Try again later.
Articles 1–20